Diagnosing Hypothyroidism
The initial test to diagnose hypothyroidism is a thyroid-stimulating hormone (TSH) test, which has high sensitivity (98%) and specificity (92%) for detecting thyroid dysfunction. 1
Diagnostic Algorithm
First-line testing:
- Measure serum TSH level
- If TSH is elevated (>6.5 mU/L), proceed to step 2
- Normal TSH (within reference range) generally rules out primary hypothyroidism
Second-line testing:
Additional testing (when indicated):
Interpretation of Results
| Condition | TSH | Free T4 | Diagnosis |
|---|---|---|---|
| Subclinical Hypothyroidism | Elevated | Normal | Mild hypothyroidism |
| Overt Hypothyroidism | Elevated | Low | Severe hypothyroidism |
| Subclinical Hyperthyroidism | Low | Normal | Mild hyperthyroidism |
| Overt Hyperthyroidism | Low | Elevated | Severe hyperthyroidism |
Clinical Context
- Hypothyroidism affects up to 5% of the general population, with another estimated 5% being undiagnosed 4
- Hashimoto's thyroiditis (autoimmune) is the cause of primary hypothyroidism in up to 85% of patients in iodine-sufficient areas 2
- Common symptoms include fatigue (68-83%), weight gain (24-59%), cognitive issues (45-48%), and menstrual irregularities (23%) 2
Important Considerations and Pitfalls
- Timing of testing: TSH exhibits diurnal variation; morning samples are preferred 5
- Biotin interference: Supplements containing biotin can interfere with assay results, causing either under or overestimation 1
- Population factors: Age, sex, ethnicity, iodine status, and pregnancy can affect TSH reference ranges 6, 5
- Medication effects: Certain medications (amiodarone, lithium, immune checkpoint inhibitors) can cause hypothyroidism 2, 6
- Central hypothyroidism: In suspected pituitary/hypothalamic dysfunction, TSH may be inappropriately normal or low; free T4 is the primary diagnostic test 3
- Non-specific symptoms: Symptoms of hypothyroidism are often non-specific, making biochemical confirmation essential 6
Monitoring Treatment
- After initiating levothyroxine, monitor TSH every 6-8 weeks until stable 2
- Once stable, monitor TSH annually to avoid overtreatment or undertreatment 2
- For central hypothyroidism, monitor free T4 and T3 concentrations rather than TSH 3
High-Risk Groups for Targeted Testing
- Women over 50 years with general symptoms
- Postpartum women
- Pregnant women and women planning pregnancy
- Patients with Down syndrome
- Individuals with high levels of radiation exposure (>20 mGy)
- Patients with type 1 diabetes 1, 2
Note that screening for hypothyroidism is not recommended for asymptomatic individuals in the general population 2.